Cargando…
Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer
[Image: see text] Doxorubicin hydrochloride (DOX) is currently used to treat orthotropic and metastatic breast cancer. Because of its side effects, the use of DOX in cancer patients is sometimes limited; for this reason, several scientists tried designing drug delivery systems which can improve drug...
Autores principales: | Di Francesco, Martina, Celia, Christian, Cristiano, Maria Chiara, d’Avanzo, Nicola, Ruozi, Barbara, Mircioiu, Constantin, Cosco, Donato, Di Marzio, Luisa, Fresta, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860091/ https://www.ncbi.nlm.nih.gov/pubmed/33553916 http://dx.doi.org/10.1021/acsomega.0c05350 |
Ejemplares similares
-
Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity
por: Voci, Silvia, et al.
Publicado: (2023) -
Multidrug Idebenone/Naproxen Co‐loaded Aspasomes for Significant in vivo Anti‐inflammatory Activity
por: d'Avanzo, Nicola, et al.
Publicado: (2022) -
Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives
por: Sahoo, Ranjan Ku., et al.
Publicado: (2014) -
Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
por: Barone, Antonella, et al.
Publicado: (2022) -
Polymerization of aniline hydrochloride in reverse of microemulsion by batch and semicontinuous process using ionic and nonionic surfactants
por: Pier Villegas, G., et al.
Publicado: (2022)